Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 2.560
-0.440 (-14.67%)
Aug 4, 2026, 2:27 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 69.01 million as of August 4, 2026. Its market cap has decreased by -31.85% in one year.
Market Cap
69.01M
Enterprise Value
130.04M
Revenue
42.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.56
ChartMarket Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 69.01M, a decrease of -89.67%. That is a compound annual growth rate of -34.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 69.01M | -21.95% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.08B |
| Circio Holding ASA | 1.95B |
| Nykode Therapeutics AS | 1.10B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 682.40M |
| Lytix Biopharma ASA | 669.03M |
| Oncoinvent ASA | 367.23M |
| SoftOx Solutions AS | 236.24M |